Citations

Clear

382 citation(s) found for "Li, Man".

Anterior spinal artery infarction causing man-in-the-barrel syndrome
Flanagan, Eoin P. , McKeon, Andrew , Weinshenker, Brian G. , Flanagan, E P , McKeon, Andrew

Mayo Clinic

Neurology Clinical Practice | June 9, 2014 | Volume: 4 | Issue: 3 | Pages: 268-269

10.1212/cpj.0000000000000032 | PMID 29473573 Get It

Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man
Lahoria, Rajat , Winder, Thomas , Lui, Jie, Al‐Owain, Mohammed, Milone, Margherita

Mayo Clinic

Muscle & Nerve | June 3, 2014 | Volume: 50 | Issue: 4 | Pages: 610-613

10.1002/mus.24302 | PMID 24889862 Get It

ABSTRACTIntroduction: Recessive mutations in the anoctamin‐5 gene (ANO5) cause a spectrum of clinical phenotypes, including limb‐girdle muscular dystrophy (LGMD 2L), distal myopathy, and asymptomatic hyperCKemia. Methods: In this report we describe our clinical, electrophysiological, pathological, and molecular findings in a subject with anoctaminopathy‐5. Results: A 49‐year‐old Arabic man from a consanguineous family presented with a 5‐year history of myalgias, hyperCKemia and an episode of unprovoked rhabdomyolysis. Muscle biopsy showed mild myopathic changes and interstitial amyloid deposition. ANO5 analysis detected a novel homozygous deletion of approximately 11.9 kb encompassing exons 13–17, predicted to be pathogenic. Conclusions: Anoctaminopathy‐5 can manifest with a phenotype reminiscent of metabolic myopathy and should be considered as a potential cause of myalgia and myoglobinuria. Amyloid deposition in the muscle biopsy is helpful for the diagnosis. A novel homozygous ANO5 deletion was identified, suggesting that screening for common mutations may have low yield in non‐European subjects. Muscle Nerve 50: 610–613, 2014
Depression in a Latino Man in New York
Oquendo, María A. , Wainberg, Milton L. , Alarcón, Renato D.

Mayo Clinic

American Journal of Psychiatry | May 1, 2014 | Volume: 171 | Issue: 5 | Pages: 506-508

10.1176/appi.ajp.2013.13101292 | PMID 24788283 Get It

HLA Class II Influences the Immune Response and Antibody Diversification to Ro60/Sjögren’s Syndrome-A: Heightened Antibody Responses and Epitope Spreading in Mice Expressing HLA-DR molecules
Paisansinsup, Tawatchai, Deshmukh, Umesh S. , Chowdhary, Vaidehi , Luthra, Harvinder S., David, Chella S., Fu, Shu Man

Mayo Clinic

The Journal of Immunology | April 21, 2014 | Volume: 168 | Issue: 11 | Pages: 5876-5884

10.4049/jimmunol.168.11.5876 | PMID 12023392 Get It

Abstract Abs to Ro/SSA Ags in the sera of patients with systemic lupus erythematosus and Sjögren’s syndrome are influenced by the HLA class II genes. To investigate the role of individual HLA class II genes in immune responses to human Ro60 (hRo60), mice lacking murine class II molecules and carrying either HLA genes DR2(DRB1*1502), DR3(DRB1*0301), DQ6(DQA1*0103/DQB1*0601), or DQ8(DQA1*0301/DQB1*0302), were immunized with rhRo60. The results show that hRo60 induces strong T and B cell responses in DR2, DR3, and DQ8 mice in comparison to weaker responses in DQ6 mice. In all mice, the majority of the dominant T cell epitopes were located in the amino portion (aa 61–185) and the carboxy portion (aa 381–525) of the hRo60 molecules. In contrast, the early dominant B cell epitopes were located in the middle and carboxy portion of the hRo60 molecule (aa 281–315 and 401–538). In DR2, DR3, and DQ8 mice, the B cell epitopes subsequently spread to the amino and carboxy portion of the hRo60 molecule but were limited to the middle and carboxy portion in DQ6 mice. The DR2 and DR3 mice produced the highest titers of immunoprecipitating Abs against hRo60 and native mouse Ro60. In addition, only DR2 mice exclusively produced immunoprecipitating Abs to native mouse Ro52 and Abs to mouse La by slot blot analysis, whereas in other strains of mice Abs to mouse La were cross-reactive with the immunogen. The results of the present study demonstrate the importance of HLA class II in controlling the immune responses to the Ro-ribonucleoprotein.
The Oral Minimal Model Method
Man, Chiara Dalla , Toffolo, Gianna , Basu, Rita , Rizza, Robert A., Cobelli, Claudio , Vella, Adrian , Dalla Man, Chiara

Mayo Clinic

Diabetes | March 20, 2014 | Volume: 63 | Issue: 4 | Pages: 1203-1213

10.2337/db13-1198 | PMID 24651807 Get It

The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism.
Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemia
He, Bai‐Liang , Shi, Xiangguo , Man, Cheuk Him , C.H., Alvin, Ekker, Stephen C. , Chow, Howard C.H., So, Chi Wai Eric , Choi, William W.L., Leung, Anskar Y.H. , Zhang, Wenqing , Zhang, Yiyue , Alvin, C. H. , Ekker, Stephen C

Mayo Clinic

Blood | March 4, 2014 | Volume: 123 | Issue: 16 | Pages: 2518-2529

10.1182/blood-2013-02-486688 | PMID 24591202 Get It

Key Points Zebrafish flt3 plays an important role in the initiation of definitive hematopoietic stem cells. Expression of human FLT3-ITD activates endogenous flt3 signaling and induces myeloid expansion.
GIM, Simulation Software of Meal Glucose—Insulin Model
Man, Chiara Dalla , Raimondo, Davide, Rizza, Robert A., Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 1 | Issue: 3 | Pages: 323-330

10.1177/193229680700100303 | PMID 19885087 Get It

Background: A simulation model of the glucose—insulin system in normal life conditions can be very useful in diabetes research, e.g., testing insulin infusion algorithms and decision support systems and assessing glucose sensor performance and patient and student training. A new meal simulation model has been proposed that incorporates state-of-the-art quantitative knowledge on glucose metabolism and its control by insulin at both organ/tissue and whole-body levels. This article presents the interactive simulation software GIM (glucose insulin model), which implements this model. Methods: The model is implemented in MATLAB, version 7.0.1, and is designed with a windows interface that allows the user to easily simulate a 24-hour daily life of a normal, type 2, or type 1 diabetic subject. A Simulink version is also available. Three meals a day are considered. Both open- and closed-loop controls are available for simulating a type 1 diabetic subject. Results: Software options are described in detail. Case studies are presented to illustrate the potential of the software, e.g., compare a normal subject vs an insulin-resistant subject or open-loop vs closed-loop insulin infusion in type 1 diabetes treatment. Conclusions: User-friendly software that implements a state-of-the-art physiological model of the glucose-insulin system during a meal has been presented. The GIM graphical interface makes its use extremely easy for investigators without specific expertise in modeling.
HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients*
Lee, Mi-Deok, Kim, Hyeon-Man, Fitzpatrick, Lorraine A. , Chung, Yoon‐Sok , Lee, Seong‐Kyu

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 8, 2014 | Volume: 85 | Issue: 3 | Pages: 1137-1142

10.1210/jcem.85.3.6476 | PMID 10720052 Get It

Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
Schiavon, Michele , Man, Chiara Dalla , Kudva, Yogish C. , Basu, Ananda , Cobelli, Claudio , Dalla Man, Chiara , Schiavon, Michele

Mayo Clinic

Diabetes Care | December 7, 2013 | Volume: 37 | Issue: 5 | Pages: 1216-1223

10.2337/dc13-1120 | PMID 24319120 Get It

OBJECTIVE The goal was to develop a new index of insulin sensitivity in patients with type 1 diabetes estimated from continuous glucose monitoring (CGM) and subcutaneous insulin delivery data under carefully controlled conditions. RESEARCH DESIGN AND METHODS The database consists of 12 subjects with type 1 diabetes, studied during breakfast, lunch, and dinner, in a clinical research unit, wearing both subcutaneous insulin pump and CGM device. Frequent blood samples were drawn for measurements of plasma glucose and insulin concentrations in order to estimate insulin sensitivity with the oral minimal model (SIMM). The new index of insulin sensitivity (SISP) was calculated with a simple algebraic formula for each meal, using only CGM and insulin pump data and compared with SIMM. RESULTS SI SP was well correlated with SIMM (r = 0.825; P < 10−8), and diurnal pattern was also similar to SIMM. CONCLUSIONS A novel method for estimating insulin sensitivity in subjects with type 1 diabetes on sensor-augmented insulin pump therapy has been presented. This new index correlates well with the reference oral minimal model estimate of insulin sensitivity. The knowledge of patient-specific insulin sensitivity and its diurnal variation can help in optimizing insulin therapy in type 1 diabetes and could also inform next-generation closed-loop control systems.